Genesis Healthcare (GEN) Receives Daily Coverage Optimism Score of 0.16

News coverage about Genesis Healthcare (NYSE:GEN) has trended somewhat positive recently, Accern reports. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Genesis Healthcare earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news stories about the company an impact score of 45.7611301622083 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the news stories that may have impacted Accern Sentiment’s scoring:

Genesis Healthcare (GEN) opened at $0.80 on Tuesday. Genesis Healthcare has a fifty-two week low of $0.60 and a fifty-two week high of $4.75. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of -0.22.

Separately, Royal Bank Of Canada reiterated a “hold” rating and issued a $2.00 price target on shares of Genesis Healthcare in a report on Wednesday, September 13th.

WARNING: This story was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://weekherald.com/2017/12/05/genesis-healthcare-gen-receives-daily-coverage-optimism-score-of-0-16.html.

About Genesis Healthcare

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply